Popular search terms:

Search Results Label

56 results found

Seqirus | About Influenza

Influenza is a common, highly contagious infection that can lead to life-threatening complications. Learn more about influenza and our cutting-edge vaccines.

https://www.seqirus.com.au/expertise/influenza
Seqirus | Influenza Expertise

Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.

https://www.seqirus.com.au/expertise
Afluria Quad™ – a four strain flu vaccine manufactured in Australia is now available

A quadrivalent flu vaccine manufactured by Seqirus locally in Melbourne, Australia is available for the 2017 Australian flu season for adults aged 18 years and older.

https://www.seqirus.com.au/news/afluria-quad-a-four-strain-flu-vaccine-manufactured-in-australia-is-now-available
Consumer Media Release APRIL 26, 2017 - FOR IMMEDIATE USE

ABOUT SEQIRUS Seqirus is the new global company created from the combined strength and expertise of bioCSL and the influenza vaccines business formerly owned by Novartis.

https://www.seqirus.com.au/-/media/seqirus-australia/news-docs/afluria-quad-2017-consumer-release--seqirus-newsroomfinal.pdf
Seqirus | Technical Development

Understand our aim to develop the next generation of influenza vaccines and how we're working to unite product platforms across the globe.

https://www.seqirus.com.au/manufacturing/technical-development
Seqirus | Our Products

Seqirus is a world leader in developing and producing influenza vaccines. Learn more about how we work with our partners to protect the global community.

https://www.seqirus.com.au/products
Seqirus | Influenza Pandemic Response Solutions

Seqirus has been on the front line of pandemic preparedness for more than a century. Learn more about our rapid vaccine production capabilities.

https://www.seqirus.com.au/expertise/influenza/pandemic-response-solutions
Seqirus | Vaccine Technologies

Seqirus employs both egg and cell-based manufacturing systems to ensure the availability of our influenza vaccines. Learn more about our optimised technology.

https://www.seqirus.com.au/manufacturing/technologies
Seqirus | A World Leader in Influenza Vaccines

Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.

https://www.seqirus.com.au/
Seqirus | Research & Development Efforts

Seqirus is working tirelessly to optimise our technology and implement transformational long-term approaches to influenza pandemic preparedness.

https://www.seqirus.com.au/r-and-d